Forward Pharma Loses Patent Appeal Trial

The appeal was against Biogen’s drug Tecfidera. Forward will lose out on future royalty payments for Biogen’s commercial product in...

Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference

Forward Pharma (NASDAQ:FWP) announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the decision of the...